Skip to Main Content

2023-2024 New Drug Update

Program Date & Time:
November 12, 2024 | 7:00pm - 9:00pm
Modalities:
  • In-person
  • Webinar
Registration Fee:
Free to $40.00
View flyer (PDF)
Additional Details
Instructional Hours:
2.00
Didactic Hours (AHEC Scholars):
2.00
Experiential Hours (AHEC Scholars):
0.00
Registration Deadline:
11/12/24 4:00 PM
Cancellation Deadline:
11/10/24 7:00 PM
Brought to you by:
Presenter(s)
Description
The purpose of the 2023-2024 New Drug Update is to provide health care professionals with an overview of the current CDC immunization schedules, including updated recommendations for influenza, COVID-19, respiratory syncytial virus (RSV), and pneumococcal vaccines. Additionally, participants will be presented with a synopsis of the 2024 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines for the treatment of COPD and a summary of the Global Initiative for Asthma (GINA) Guidelines for the treatment of asthma. This activity will also include a discussion of the American College of Cardiology/American Heart Association/Heart Failure Society of America (ACC/AHA/HFSA) 2022 revised treatment Guidelines for the Management of Patients with Heart Failure and an in-depth review of the ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction (HFpEF). The presentation will also summarize efficacy and safety data for newer weight loss medications, including Glucagon-Like-Peptide-1 (GLP-1) and Glucose-Dependent-Insulinotropic Polypeptide (GIP) Receptor Agonists. Finally, this multidisciplinary CE program will conclude with a discussion of potential therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD).

Keywords: drug update, pharmacy, provider, np

Objectives

At the completion of this activity, participants will be able to:

  • Discuss the new/updated vaccines and CDC recommendations including influenza, COVID-19. RSV and pneumococcal disease.
  • Describe the updated 2024 GOLD Guidelines for patients with COPD and 2024 GINA Guidelines for patients with asthma.
  • Discuss the updated American College of Cardiology/American Heart Assoc/Heart Failure Society of America 2022 revised Guidelines for the Management of Patients with Heart Failure and the 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction.
  • Describe the updated efficacy and safety data for the newer weight loss medications.
  • Discuss the significance and potential treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) the new name for non-alcoholic fatty liver disease (NAFLD).
Disclosures
Pee Dee AHEC’s conflict of interest policy requires faculty to disclose any real or apparent commercial affiliations related to the content of their presentations/educational materials. Dr. Reagan Barfield, Dr. Spencer Morris, Ms. Kimberly Morris and Ms. Beejay Parnell declare no conflicts of interest or financial interests in any product or service mentioned in this program, including employment, gifts, stock holdings and/or honoraria.
Credits Available
  • Registered Nurses
    SC Nurses Association
    Credit Statement

    Pee Dee AHEC (Area Health Education Center) is approved as a provider of nursing continuing professional development by South Carolina Nurses Association an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Upon successful completion of this program, attendees will receive 2 contact hours.

  • Physicians
    McLeod Health CME
    Credit Statement
    McLeod Health is accredited by the Medical Association of Georgia (MAG) to provide continuing medical education for physicians. McLeod Health designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Pharmacists
    Southeastern CME Consultants
    Credit Statement
    The Southeastern Continuing Medical Education Consultants, LLC., is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number for this program is 0499-9999-24-006-L01-P. This continuing pharmacy education activity provides 2.0 contact hours (0.2 CEUs) of continuing education credit for pharmacist. A completed attendance verification form and program evaluation must be submitted in order to received CPE credit. No fractional hours of credit will be given.
  • APRNs
    SC Nurses Association (Pharma)
    Credit Statement

    Pee Dee AHEC (Area Health Education Center) is approved as a provider of nursing continuing professional development by South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

    Upon successful completion of this program, APRNs will receive 2.0 PH (Pharmacology Hours).

  • All other participants
    Area Health Education Consortium
    Credit Statement
    This program provides 0.2 CEUs by Pee Dee AHEC and meets South Carolina AHEC Best Practice Standards.
  • AHEC Scholars
    Area Health Education Consortium Student
    Credit Statement
    Participation recognition only: This 2 hour(s) program is presented by SC AHEC.
Locations/Participation Options
  • McLeod Pavilion First Floor Conference Room
    Location:
    Florence , SC Details
    Status:
    Open
  • Webinar
    Details
    Status:
    Open
Contact(s)

If you have questions about the credits, location/video conference information, or any other details specific to this particular program, please reach out to the contact(s) below:

  • Name:
    Beejay Parnell
    Phone:
    843-777-5347
    Email:
    beejay.parnell@mcleodhealth.org
  • Name:
    Kimberly Morris
    Phone:
    843-777-5343
    Email:
    kimberlymorris@mcleodhealth.org
If you have questions related to registering or using the AHEC Learning Portal, please contact ofte@musc.edu.

Working...